News & Updates

Another Incredible Year

A look back to the future in ALS research Twenty-twenty four was a busy year at NDR! We made incredible progress, but we still have far...

https://alsnewstoday.com/news/feeding-tube-best-placed-before-major-weight-loss-als/

https://alsnewstoday.com/news/healthcare-costs-increase-als-progression-biogen-us-study/

Amyotrophic Lateral Sclerosis is a spectrum of diseases that needs a broad treatment approach Siobhan P Ellison DVM PhD1

June 21, 2024 The last subjects for the clinical trial using FC-12738, affectionally called TVALA, had their final follow up visit on ...

In hindsight, Richard Helms remembered he had a non-painful limp in 2018. After multiple consults he was introduced to ALS, that was in...

We are happy to announce the first patients are being screened for entry into the clinical trial for our drug TVALA! This Phase 1 study...

We are hopeful that TVALA will reduce p53 expression in people with ALS. There are two recent publications that give us hope. The first...